Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study

Mälardalen University

Status

Enrolling

Conditions

Breast Cancer

Colorectal Cancer (CRC)

Neoadjuvant Therapy

Adjuvant Therapy

Prostate Cancer

Treatments

Behavioral: Digital self-management program

Study type

Interventional

Funder types

Other

Identifiers

NCT06719206

2020/1120

Details and patient eligibility

About

Summary

Reducing sedentary behavior during treatment is important to reduce the risk of future health problems in individuals undergoing cancer treatment. Therefore, the goal of this project is with a multicenter randomised controlled design investigate whether a digital support intervention during ongoing neo- or adjuvant cancer treatment for breast, prostate or colon cancer is effective in reducing sedentary lifestyle and improving well-being in the short and long term.

Full description

Description of the project

This project is about investigating the effect of a digital support intervention to reduce sedentary behavior in people with breast, prostate, or colorectal cancer during neo- or adjuvant cancer treatment. The digital support intervention has been developed with patients and researchers and consists of existing high-quality technology that provides support for setting and following goals. The people who use the digital support intervention also receive support from a physiotherapist to set goals for reduced sedentary time and get to choose which activities will replace the time spent sedentary.

The goal of the project

The goal of the project is to investigate the effects of a digital support intervention on reduced sedentary and well-being during ongoing cancer treatment, both in the short and long term. In addition, the project will study the health-economic effects, and climate benefits of using the digital support intervention. By focusing on reducing a sedentary lifestyle and replacing it with daily activities and/or physical activity, the health of individuals is expected to be positively affected in the short term through, for example, increased well-being and reduced side effects from cancer treatment, and the long term through a reduced risk of developing complications and new illness related to the cancer treatment, such as cardiovascular disease.

Enrollment

172 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Individuals diagnosed with breast, prostate, or colorectal cancer planned for or resently started neo- or adjuvant treatment (e.g. chemotherapy, radiotherapy, endocrine treatment) at the hospitals in Uppsala and Västerås, Sweden.

Exclusion criteria

Individuals diagnosed with dementia.
Individuals diagnosed with severe psychiatric disease.
Individuals with severe loss of vision, or communicative ability.
Individuals who cannot walk independently indoors with or without a walking aid.
Individuals completed treatment for other cancer diseases less than 12 months ago or not recovered from previous cancer treatment.